Why Mainz Biomed Stock Is Crashing Today

Why Mainz Biomed Stock Is Crashing Today

Shares of Mainz Biomed (NASDAQ: MYNZ) had crashed by 26.4% as of 11:38 a.m. ET on Wednesday. The big decline came after the molecular genetics diagnostic company announced the pricing of a public follow-on stock offering. Mainz plans to sell 1.5 million shares at $15 per share.